CoChat

Apolipoprotein C-III and hepatic triglyceride-rich lipoprotein production

Yao, Zemin, Wang, Yuwei · 2012 · Current Opinion in Lipidology

The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.

Abstract

PURPOSE OF REVIEW: A strong positive correlation between plasma apolipoprotein (apo) C-III and triglyceride concentrations has been invariably observed in human and animal studies. The hypertriglyceridemic effect of apo C-III has been conventionally explained by its extracellular roles in inhibiting lipolysis catalysed by lipoprotein lipase and attenuating triglyceride-rich lipoprotein clearance through receptor-dependent and/or independent mechanisms. However, recent experimental evidence suggests that apo C-III may also play an intracellular role in promoting hepatic triglyceride-rich lipoprotein production. RECENT FINDINGS: Kinetic studies with humans and genetically modified mice have shown that apo C-III is linked with increased production of triglyceride-rich lipoproteins, such as very-low-density lipoprotein 1 (VLDL1). Mutational studies on human apo C-III variants (originally identified in humans with hypotriglyceridemia or hyperalphalipoproteinemia) provide the structure-function analysis of human apo C-III, demonstrating that loss-of-function mutations within human apo C-III impair the assembly and secretion of triglyceride-rich VLDL1 under lipid-rich conditions. SUMMARY: The current review summarizes recent experimental evidence for an intrahepatic role of human apo C-III in promoting mobilization and utilization of triglyceride during VLDL1 assembly/secretion. Understanding mechanisms by which hepatic apo C-III expression is regulated under insulin resistance and diabetic conditions will lead to better and more rational strategies for the prevention and treatment of diabetic hypertriglyceridemia that is closely related to premature atherosclerosis.

Overview

Integrity signals

Registry

Crossref · 10.1097/mol.0b013e328352dc70

Cites

60 of 60 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 60 references

Cited by

See all 102

Metadata

Authors
Yao, Z., & Wang, Y.
Affiliations
University of Ottawa (CA)
Corresponding author
Yao, Zemin
Venue
Current Opinion in Lipidology
Published
2012-06
Volume
23
Issue
3
Pages
206-212
ISSN
0957-9672 (ISSN-L)
OpenAlex
W2041953515
Cited by
100
References
60
Citations by year
2026: 2 · 2025: 5 · 2024: 6 · 2023: 4 · 2022: 2 · 2021: 8 · 2020: 7 · 2019: 9 · 2018: 7 · 2017: 11 · 2016: 8 · 2015: 12 · 2014: 10 · 2013: 7 · 2012: 2
FWCI
1.62
Type
journal article
Language
en
Open access
closed
Locations
  • Current Opinion in Lipidology (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Heart and Stroke Foundation of Canada
  • Canadian Institutes of Health Research
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
Keywords
apolipoprotein C-III, hypertriglyceridemia, hypotriglyceridemia, hyperalphalipoproteinemia, insulin resistance, diabetes mellitus, triglyceride mobilization, lipoprotein lipase
MeSH terms
Animals, Gene Expression Regulation, Homeostasis, Humans, Liver, Triglycerides, Apolipoprotein C-III

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Apolipoprotein C-III and hepatic triglyceride-rich lipoprotein production. https://app.cochat.ai/papers/10.1097/mol.0b013e328352dc70
The paper
Yao, Z., & Wang, Y. (2012). Apolipoprotein C-III and hepatic triglyceride-rich lipoprotein production. Current Opinion in Lipidology. https://doi.org/10.1097/mol.0b013e328352dc70

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.